Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial ...
Alliance Cancer Specialists, Horsham, Pennsylvania, United States
Hospital ClÃnico Universitario de Valencia, València, Spain
Alabama Oncology, Birmingham, Alabama, United States
Southern Cancer Center, Daphne, Alabama, United States
The Oncology Institute of Hope and Innovation, Fort Lauderdale, Florida, United States
Rocky Mountain Cancer Centers, Lone Tree, Colorado, United States
Hospital CUF Descobertas, Lisboa, Portugal
Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
Institut Curie, Saint-Cloud, France
Compassionate Care Research Group Inc., Riverside, California, United States
Emad Ibrahim, M.D., Inc., Redlands, California, United States
The Oncology Institute of Hope and Innovation, Santa Ana, California, United States
Celerion, Tempe, Arizona, United States
Northwestern University, Chicago, Illinois, United States
Istituto Europeo di Oncologia (IEO) I.R.C.C.S., Milano, Italy
Gundersen Center for Cancer and Blood Disorders, La Crosse, Wisconsin, United States
Johns Hopkins, Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States
University of California San Diego Medical Center - Hillcrest, San Diego, California, United States
Sharp Memorial Hospital, San Diego, California, United States
Investigational Site, New Haven, Connecticut, United States